Alex Federation says AI drug-discovery models proliferate but lack lab validation, urges third‑party testing

Alex Federation attended an AI drug discovery conference and reports many new models lack experimental lab validation, with most evaluated on the same public datasets; he argues for more third‑party and in‑house lab testing and discusses challenges in choosing small‑molecule targets and success metrics.

No comments yet.